4//SEC Filing
LIXTE BIOTECHNOLOGY HOLDINGS, INC. 4
Accession 0001493152-15-000941
$LIXTCIK 0001335105operating
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 8:28 PM ET
Size
8.3 KB
Accession
0001493152-15-000941
Insider Transaction Report
Form 4
Riggs Arthur
10% Owner
Transactions
- Purchase
Preferred Stock
2015-03-17$10.00/sh+175,000$1,750,000→ 175,000 total(indirect: See Footnote)Exercise: $0.80From: 2015-03-17→ Common (2,187,500 underlying)
Holdings
- 4,850,000(indirect: By Trust)
Common Stock
Riggs Jane Merrill
10% Owner
Transactions
- Purchase
Preferred Stock
2015-03-17$10.00/sh+175,000$1,750,000→ 175,000 total(indirect: See Footnote)Exercise: $0.80From: 2015-03-17→ Common (2,187,500 underlying)
Holdings
- 4,850,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Effective March 17, 2015, the Arthur and Jane Riggs 1990 Revocable Trust purchased 175,000 shares (the "Preferred Shares") of the Company's Series A Convertible Preferred Stock at $10.00 per share. Each Preferred Share may be converted, at the option of the holder, into 12.5 common shares (subject to customary anti-dilution provisions) and the Preferred Shares are subject to mandatory conversion at the conversion rate in the event of a merger or sale transaction resulting in gross proceeds to the Company of at least $21,875,000. If fully converted, the Preferred Shares would convert into 2,187,500 shares of common stock, representing an effective price per common share of $0.80. Arthur Riggs and Jane Riggs are co-trustees of the Trust and share voting and dispositive power over the Preferred Shares. They share the same address.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001335105
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 8:28 PM ET
- Size
- 8.3 KB